|
Pseudomonas aeruginosa in Patients with
Cystic Fibrosis
Read the Chapter
Sliding Table of
Contents on the left of the screen
Vignettes
Dales L, et al.
Combination Antibiotic Susceptibility of Biofilm-grown
Burkholderia cepacia and Pseudomonas aeruginosa Isolated from
Patients with Pulmonary Exacerbations of Cystic Fibrosis. Eur J
Clin Microbiol Infect Dis 2009;28:1275-1279.
Tables
Table 1:
Maintenance Therapy of Pseudomonas aeruginosa
Chronic Infection
Table 2:
Definition of a Pulmonary Exacerbation in Cystic Fibrosis
Table 3: Four
Characteristics Most Associated with Treatment for Pulmonary Exacerbation in
Each Age Group (Age group in years)
Table 4:
Monitoring Cystic Fibrosis Patients During Pulmonary Exacerbation with
Intravenous (IV) Antibiotics
Table 5:
Distinctions between Acute & Chronic Lung Infections
Table 6: Hospital
Treatment of Pulmonary Exacerbation
Table 7: Anti
Pseudomonal Intravenous (IV)
Antimicrobials and Dosing in Cystic Fibrosis Patients
Authors
Kathryn S. Moffett, M.D.
|
www.antimicrobe.org